MARKET

PHIO

PHIO

Phio Pharmaceuticals Corp
NASDAQ
0.6870
-0.1429
-17.22%
Opening 14:56 04/23 EDT
OPEN
0.7189
PREV CLOSE
0.8299
HIGH
0.8300
LOW
0.6551
VOLUME
599.84K
TURNOVER
0
52 WEEK HIGH
6.85
52 WEEK LOW
0.5000
MARKET CAP
3.15M
P/E (TTM)
-0.1322
1D
5D
1M
3M
1Y
5Y
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation tumbled 6.5% to $179.20 on Tuesday. The company reported worse-than-expected quarterly financial results. Cyngn Inc. Shares jumped 100% after the company was chosen to supply John Deere with industrial automation. Pineapple Energy Inc. And Virgin Galactic Holdings, Inc. Were among the stocks moving in today's mid-day session.
Benzinga · 1h ago
BUZZ-U.S. STOCKS ON THE MOVE-Calix, Fiserv, Quest Diagnostics
U.S. Stocks set to rise at open as some growth and chip stocks gain. Dow e-minis were up 0.28% in early trading. Spotify Technology, Fiserv, Quest Diagnostics among top percentage gainers. Investors digested a raft of quarterly earnings updates.
Reuters · 6h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. Nuwellis shares increased by 24.1% and VolitionRX stock increased by 16.66% during the same time period. Losers Abeona Therapeutics and OncoCyte stock declined by 45.7% and 16.34% respectively.
Benzinga · 7h ago
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. Rose sharply in today's pre-market trading. The company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash. Pineapple Energy Inc. Shares gained 38% to $0.0632 after falling 10% on Monday. ImmunityBio, Inc., AGBA Group Holding Limited and HWH International were among the stocks moving in pre- market trading.
Benzinga · 7h ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
HWH International (NASDAQ:HWH) stock is rocketing more than 64% alongside heavy pre-market trading. Pineapple Energy shares are soaring close to 40% on plans to regain listing compliance. The biggest pre- market stock movers on Tuesday morning are delisting updates, proposed public offerings, earnings reports and more.
Investorplace · 8h ago
12 Health Care Stocks Moving In Monday's After-Market Session
Nuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. Sensei Biotherapeutics and Cognition Therapeutics among the gainers. Losers include Phio Pharma and Rigel Pharmaceuticals.
Benzinga · 23h ago
Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
Phio Pharmaceuticals Corp is presenting new data about its lead clinical product candidate, PH-762. The shares are trading higher on a strong session volume of over 5 million. The company's lead product candidate is an INTASYL compound. The drug is being tested as a neoadjuvant therapy for cancer.
Benzinga · 1d ago
Phio's Intratumoral Injection Of PH-762 Significantly Inhibits Tumor Growth In Murine Tumor Models And May Generate Memory-Specific T Cells; Injection In Murine Tumors Shows The Compound Is Well Tolerated
-Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinoma. Data will be presented at the American Society of Gene and Cell Therapy on May 8.
Benzinga · 1d ago
More
About PHIO
Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The Company's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. It is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. The Company's pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. PH-894 is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby affecting the immune system as well as the tumor.

Webull offers Phio Pharmaceuticals Corp stock information, including NASDAQ: PHIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHIO stock methods without spending real money on the virtual paper trading platform.